Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1N acetyl cysteine----2件: 6, 19 💬
2N acetyl L cysteine----1件: 60 💬
3N acetyl L leucine----1件: 19 💬
4N acetylcysteine----1件: 13 💬
5N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-YL]PROP-2-EN-1-ylidene]amino]guanidinium acetate----1件: 46 💬
6N(4,5BIS methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate----1件: 113 💬
7N-(4,5-BIS methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate----1件: 113 💬
8N-(5-hydroxy-2,4- BIS(trimethylsilyl)phenyl)-4-OXO- 1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
9N-(5-hydroxy-2,4-BIS(trimethylsilyl)phenyl)-4-OXO-1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
10N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-YL)cyclopropanecarboxamide----1件: 49 💬
11N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-YL)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299 💬
12N-0923----1件: 6 💬
13N-3 LC-pufa----1件: 46 💬
14N-3 polyunsaturated fatty acids----1件: 96 💬
15N-[1-((5-cyanopyridin-2-YL)methyl)-1H-pyrazol-3-YL]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide----1件: 154 💬
16N-acetyl cysteine----6件: 13, 34, 85, 88, 296, 310 💬
17N-acetyl-cysteine----1件: 84 💬
18N-acetyl-L leucine----1件: 19 💬
19N-acetyl-L-leucine1件: L-Acetylleucine---2件: 19, 65 💬
20N-acetylcystein----1件: 299 💬
21N-acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --14件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
22N-acetylcysteine amide----1件: 19 💬
23N-acetylcysteine capsule----1件: 6 💬
24N-acetylcysteine syrup----1件: 53 💬
25N-acetylgalactosamine 4-sulfatase----1件: 19 💬
26N-acetylneuraminic acid----1件: 30 💬
27N-carbamylglutamate1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 3件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬2件: 245, 246 💬
28N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----1件: 28 💬
29N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13 💬
30N-thymidine----2件: 215, 216 💬
31N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----1件: 96 💬
32N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----1件: 96 💬
33N. meningitidis group C (strain C11) oligosaccharide conjugated TO corynebacterium diphtheriae CRM197 adsorbed ON aluminum hydroxide----1件: 11 💬
34N. meningitidis group C polysaccharide----1件: 14 💬
35N. meningitidis group W135 oligosaccharide conjugated CRM197----1件: 13 💬
36N/A----1件: 61 💬
37N02bg10----1件: 13 💬
38N03ax12----1件: 13 💬
39N04bc07----1件: 6 💬
40N04bd02----1件: 6 💬
41N04bd03----1件: 6 💬
42N06dx01----1件: 13 💬
43N1,N3-BIS(2-mercaptoethyl) isophthalamide----2件: 5, 17 💬
44N15-thymidine----1件: 215 💬
45N6022----1件: 299 💬
46N91115----1件: 299 💬
47NA----1件: 58 💬
48NA18F----1件: 13 💬
49Nabilone1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 6, 13, 97, 127 💬
50Nabilone 0.25 MG1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
51Nabiximols1件: Nabiximols1件: Nabiximols 💬 --1件: 13 💬
52Nabiximols - sativex3件: Cannabidiol,
Dronabinol,
Nabiximols
3件: Dronabinol ,
Nabiximols ,
Cannabidiol 💬
2件: CNR1,
CNR2 💬
4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
53NAC----6件: 8, 34, 51, 85, 90, 299 💬
54NAC effervescent tablets----1件: 90 💬
55Nacl----1件: 227 💬
56Nacom----1件: 6 💬
57Nacom 100----1件: 6 💬
58Nacom levodopa+cardidopa----1件: 6 💬
59Nacystelyn1件: Nacystelyn---1件: 299 💬
60Nadh1件: NADH---1件: 302 💬
61Nadolol1件: Nadolol1件: Nadolol 💬 2件: ADRB1,
ADRB2 💬
13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
62Naglazyme1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
63NAL----2件: 6, 299 💬
64NAL ER----1件: 85 💬
65Nalbuphine ER 108 MG1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
66Nalbuphine ER 27 MG1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
67Nalbuphine ER 54 MG1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
68Nalbuphine extended-realease (ER) tablets1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
69Nalbuphine extended-release (ER) tablets1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
70Nalbuphine hydrochloride1件: Nalbuphine2件: Nalbuphine hydrochloride ,
Nalbuphine 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
71Nalmefene1件: Nalmefene3件: Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 93 💬
72Naloxone hydrochloride1件: Naloxone3件: Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
73Naloxone hydrochloride dihydrate1件: Naloxone3件: Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
74Naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 10, 13, 96, 226 💬
75Naltrexone cloridrato1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
76Naltrexone hydrochloride1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬9件: 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
77Naltrexone-HCL1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬
3件: OPRD1,
OPRK1,
OPRM1 💬
7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
78Namilumab1件: Namilumab---2件: 46, 84 💬
79Namisol----2件: 13, 298 💬
80Namuscla1件: Mexiletine2件: Mexiletine hydrochloride ,
Mexiletine 💬
5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
81Nandrolone1件: Nandrolone1件: Nandrolone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 60 💬
82Nandrolone decanoate2件: Nandrolone,
Nandrolone decanoate
2件: Nandrolone decanoate ,
Nandrolone 💬
1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 60, 85 💬
83Nanobody directed towards THE human A1 domain OF VON willebrand factor----1件: 64 💬
84Nanobubble drink----1件: 46 💬
85Nanocort----3件: 13, 46, 97 💬
86Nanocurcumin----2件: 13, 271 💬
87Nanogam----1件: 63 💬
88Nanogam 100 MG/ML----1件: 65 💬
89Nanogam® 50 MG/ML----1件: 65 💬
90Nanoparticulated rebamipide1件: Rebamipide1件: Rebamipide 💬 --1件: 46 💬
91NAP----2件: 96, 240 💬
92Napba----1件: 251 💬
93Naprosyn1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
94Naprosyn 500 MG1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
95Naprosysn----1件: 271 💬
96Naproxen1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271 💬
97Naproxen 10 MG/KG1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
98Naproxen oral suspension1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
99Naproxen sodium1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107 💬
100Naproxen sodium 550MG tablet1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
101Naproxen tablet 500 MG1件: Naproxen2件: Naproxen ,
Naproxen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
102Nardil----1件: 6 💬
103Narsoplimab1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 66, 222 💬
104Nasal aztreonam----1件: 299 💬
105Nasal brushing----1件: 299 💬
106Nasal nitric oxide testing----1件: 340 💬
107Nasal rinsing with xylitol----1件: 299 💬
108Nasojejunal (NJ) tube----1件: 6 💬
109Nasonex----1件: 98 💬
110Nasopharyngeal swabs----1件: 46 💬
111Natalizumab1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
112Natalizumab 300 MG IN 15 ML injection1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
113Natalizumab discontinuation1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
114Natalizumab FOR IV infusion1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
115Natalizumab FOR subcutaneous injection1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
116Natalizumab IV1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
117Natalizumab SC1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
118Natalizumab treatment1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
119Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
120Natpar1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTHR2 💬
4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
121Natpara----1件: 235 💬
122Natpara/natpar----1件: 235 💬
123Natriumchlorid1件: Sodium chloride1件: Sodium chloride 💬 --1件: 288 💬
124Natriumklorid 9MG/ML----1件: 46 💬
125Natriuretic peptide----1件: 276 💬
126Natrunix----1件: 46 💬
127Natrunix 400 MG----1件: 46 💬
128Natural herbs OF coconut, aloe vera, and pepperint----1件: 53 💬
129Natural matrix protein (NMP) fibers----1件: 70 💬
130Navenibart----1件: 65 💬
131Navepegritide----1件: 276 💬
132Navocaftor1件: Navocaftor1件: Navocaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
133NBI-5788----1件: 13 💬
134NBI-74788----1件: 81 💬
135NBI-77860----1件: 81 💬
136NBI-827104----1件: 154 💬
137Nbmi----2件: 5, 17 💬
138NBT-NM108----1件: 193 💬
139NBTX-001----1件: 6 💬
140NC 1 cell therapy----1件: 117 💬
141NCA 500MG----1件: 93 💬
142ND-L02-S0201 FOR injection----1件: 85 💬
143ND0611----1件: 6 💬
144ND0612----1件: 6 💬
145ND0612 (levodopa/carbidopa solution) + morning oral IR-LD/CD1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
146ND0612 solution FOR SC infusion----1件: 6 💬
147ND1421----1件: 6 💬
148ND1587----1件: 6 💬
149ND1589----1件: 6 💬
150ND1590----1件: 6 💬
151ND1702----1件: 6 💬
152NDV-3A----1件: 65 💬
153NDX-3315 and NDX-33241件: NDX-3315---1件: 98 💬
154NE3107----1件: 6 💬
155NEAR-infrared-induced autofluorescence and indocyanine green NEAR-infrared angiography----1件: 235 💬
156NEB/01-07----1件: 299 💬
157Nebcin----1件: 299 💬
158Nebcinal----1件: 299 💬
159Nebcinal tobi----1件: 299 💬
160Nebcine----1件: 299 💬
161Nebicapone1件: Nebicapone---1件: 6 💬
162Nebido----1件: 13 💬
163Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection----1件: 13 💬
164Nebivolol1件: Nebivolol2件: Nebivolol ,
Nebivolol hydrochloride 💬
1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 113, 167 💬
165Nebivolol 5 MG1件: Nebivolol2件: Nebivolol ,
Nebivolol hydrochloride 💬
1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
166Nebulization tobramycin1件: Tobramycin2件: Tobramycin ,
Tobramycin sulfate 💬
--1件: 299 💬
167Nebulized combination ipratropium bromide with salbutamol----1件: 86 💬
168Nebulized ensifentrine suspension----1件: 299 💬
169Nebulized ipratropium bromide----1件: 86 💬
170Nebulizer----1件: 6 💬
171Nedosiran1件: Nedosiran1件: Nedosiran sodium 💬 1件: LDH 💬 7件: Central carbon metabolism in cancer, Cysteine and methionine metabolism, Glucagon signaling pathway, Glycolysis / Gluconeogenesis, HIF-1 signaling pathway, Propanoate metabolism, Pyruvate metabolism 💬1件: 234 💬
172Needle biopsy OF THE vastus lateralis muscle----1件: 113 💬
173Nefecon----1件: 66 💬
174Nefecon 16MG daily----1件: 66 💬
175Neflamapimod1件: Neflamapimod1件: Neflamapimod 💬 4件: P38,
P38,
P38,
P38 💬
62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬1件: 8 💬
176Neisseria meningitidis group A polysaccharide conjugated with tetanus toxoid carrier protein1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬
--1件: 50 💬
177Neisseria meningitidis group W-135 polysaccharide conjugated TO teta----1件: 50 💬
178Neisseria meningitidis group W-135 polysaccharide conjugated TO tetanus toxoid carrier protein1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬
--1件: 50 💬
179Nelfinavir1件: Nelfinavir2件: Nelfinavir mesylate ,
Nelfinavir 💬
--3件: 49, 265, 331 💬
180Nelfinavir mesylate1件: Nelfinavir2件: Nelfinavir mesylate ,
Nelfinavir 💬
--1件: 265 💬
181Nelotanserin1件: Nelotanserin1件: Nelotanserin 💬 1件: HTR2 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
182Nemolizumab1件: Nemolizumab1件: Nemolizumab 💬 1件: IL31RA 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 51 💬
183NEO-ASA----1件: 251 💬
184NEO-GAA----1件: 256 💬
185NEO-recormon----1件: 18 💬
186NEOD001----1件: 28 💬
187Neofordex1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
188Neofuse1件: Rexlemestrocel-L---1件: 70 💬
189Neogaa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
190Neogaa or avalglucosidase alfa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
191Neokare breast milk fortifier----1件: 291 💬
192Neomycin1件: Neomycin3件: Neomycin sulfate ,
Neomycin palmitate ,
Neomycin 💬
--3件: 96, 97, 296 💬
193Neophyr 1000PPM MOL/MOL----1件: 294 💬
194Neoral1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 97, 222 💬
195Neoral 100 MG, capsule molle----1件: 60 💬
196Neoral oral solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 269 💬
197Neoral soft gelatin capsules1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 97, 269 💬
198Neorecormon2件: Epoetin beta,
Erythropoietin
5件: Epoetin alfa ,
Epoetin beta ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬
1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬2件: 13, 18 💬
199Neostigmine1件: Neostigmine3件: Neostigmine bromide ,
Neostigmine methylsulfate ,
Neostigmine 💬
1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
200Neovasculgen----1件: 51 💬
201Neramexane mesylate1件: Neramexane---1件: 13 💬
202Neratinib1件: Neratinib2件: Neratinib ,
Neratinib maleate 💬
3件: EGFR,
ERBB2,
ERBB4 💬
49件: Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬1件: 34 💬
203Neridronic acid1件: Neridronic Acid---1件: 6 💬
204Nerispirdine1件: Nerispirdine---1件: 13 💬
205Nerispirdine hydrochloride1件: Nerispirdine---1件: 13 💬
206Nerixia*IM EV 1F 25MG----1件: 6 💬
207Nerixia*infus IV conc 2F 100MG----1件: 274 💬
208Nerve block----1件: 46 💬
209Nerve growt factor - 2.5S----1件: 90 💬
210Nerve growth factor1件: Nerve Growth Factor---4件: 2, 3, 53, 90 💬
211Nessuno----1件: 96 💬
212Nestle impact immunonutrition----1件: 97 💬
213NEU-120----1件: 6 💬
214NEU-411----1件: 6 💬
215Neupogen1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬4件: 13, 28, 51, 285 💬
216Neupro1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
217Neupro - 2 MG/24 H + 4 MG/24 H + 6 MG/24 H+ 8 MG/24 H cerotto otto transdermico 7 cerotti + 7 cerotti + 7 cerotti + 7 cerotti trandermici IN bustina1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 127 💬
218Neupro 2 MG/24 H parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
219Neupro 2 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
220Neupro 2MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
221Neupro 2MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
222Neupro 4 MG / 24 HR. transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
223Neupro 4 MG/24 H parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
224Neupro 4 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
225Neupro 4MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
226Neupro 4MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
227Neupro 4MG/24HR transdermal patch----1件: 6 💬
228Neupro 6 MG/24 H parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
229Neupro 6 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
230Neupro 6MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
231Neupro 6MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
232Neupro 8 MG/24 H parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
233Neupro 8 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
234Neupro 8MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
235Neupro*28CER 2MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
236Neupro*28CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
237Neupro*28CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
238Neupro*28CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
239Neupro*7CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
240Neupro*7CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
241Neupro*7CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
242Neupro® 8 MG/24 H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
243Neuraceq----1件: 6 💬
244Neuro-psychological assessment----1件: 240 💬
245Neurobloc----1件: 6 💬
246Neurocognitive assessment----1件: 6 💬
247Neurocognitive testing----1件: 19 💬
248Neuroepo----1件: 6 💬
249Neurohormonal mechanisms----1件: 127 💬
250Neurological evaluation----1件: 25 💬
251Neurology exam----1件: 19 💬
252Neuromodulation - sacral nerve stimulation----1件: 26 💬
253Neuromuscular electrical stimulation delivered using THE electrical therapy device empi 300 PV----1件: 13 💬
254Neuromuscular evaluation----1件: 13 💬
255Neurontin1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
256Neurontin 300 MG hard capsule1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
257Neuropsychological assessment----1件: 127 💬
258Neuropsychological assessments----1件: 34 💬
259Neurostimulation----1件: 6 💬
260Neurovax1件: NeuroVax---1件: 13 💬
261Neurovax 300UG/ML dose FOR IM injection1件: NeuroVax---1件: 13 💬
262Neurpro----1件: 6 💬
263Neutralizing antibody TO SPK-3006 capsid----1件: 256 💬
264Nevanimibe hydrochloride1件: Nevanimibe2件: Nevanimibe ,
Nevanimibe hydrochloride 💬
--2件: 75, 81 💬
265Nevirapine1件: Nevirapine1件: Nevirapine 💬 --1件: 265 💬
266NEW formulation adalimumab----1件: 46 💬
267NEW formulation etanercept----1件: 46 💬
268NEW formulation OF rebif - human interferon BETA-1A1件: Human interferon beta1件: Interferon beta 💬 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
269NEW thermo stable formulation OF epoprostenol sodium1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬
1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
270Newgam----3件: 14, 63, 65 💬
271Newnorm----1件: 65 💬
272Nexavar1件: Sorafenib2件: Sorafenib tosylate ,
Sorafenib 💬
8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬
87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
273Nexiguran ziclumeran----1件: 28 💬
274Nexium 10 MG1件: Esomeprazole5件: Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬
2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 234 💬
275Nexium 201件: Esomeprazole5件: Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬
2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 299 💬
276Next generation sequencing----1件: 171 💬
277Nexviadyme1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬 1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
278NFC-1----1件: 203 💬
279NFS-02 injection1件: NFS-02---1件: 302 💬
280NFX-179 GEL----1件: 34 💬
281NG-monomethyl-L-arginine1件: Tilarginine1件: Tilarginine acetate 💬 3件: NOS1,
NOS2,
NOS3 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Apelin signaling pathway, Arginine and proline metabolism, Arginine biosynthesis, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Chagas disease, Circadian entrainment, Diabetic cardiomyopathy, Dilated cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hormone signaling, Hypertrophic cardiomyopathy, Insulin resistance, Leishmaniasis, Lipid and atherosclerosis, Long-term depression, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Peroxisome, Pertussis, Phagosome, Platelet activation, Relaxin signaling pathway, Salivary secretion, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬1件: 67 💬
282NG01 - autologous bone marrow derived human stromal cells----1件: 13 💬
283NGGT002----1件: 240 💬
284NGGT006----1件: 79 💬
285NGM282----2件: 93, 94 💬
286NGN-1011件: NGN-101---1件: 19 💬
287NGN-4011件: NGN-401---1件: 156 💬
288NGS----1件: 61 💬
289NGX2671件: NGX267---1件: 53 💬
290NI-0101----1件: 46 💬
291NI-03----1件: 298 💬
292NI-0501----3件: 49, 54, 107 💬
293NI-071----1件: 46 💬
294NI-0801----1件: 93 💬
295Niacin1件: Niacin1件: Niacin 💬 --2件: 6, 265 💬
296Niacinamide1件: Nicotinamide1件: Niacinamide 💬 --3件: 6, 13, 67 💬
297Nicardipine1件: Nicardipine2件: Nicardipine hydrochloride ,
Nicardipine 💬
4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 70, 86 💬
298Niclosamide1件: Niclosamide1件: Niclosamide 💬 --2件: 46, 97 💬
299Nicolon----1件: 97 💬
300Nicorette 10MG/ 16 H1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
301Nicorette 15 MG/ 16 H1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
302Nicorette 5 MG/ 16 H1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
303Nicotinamid riboside----1件: 13 💬
304Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --5件: 6, 18, 49, 107, 162 💬
305Nicotinamide adenine dinucleotid/nicotinamide mononucleotide1件: Nicotinamide1件: Niacinamide 💬 --1件: 63 💬
306Nicotinamide mononucleotide2件: Nicotinamide,
Nicotinamide Mononucleotide
1件: Niacinamide 💬 --1件: 97 💬
307Nicotinamide riboside3件: Nicotinamide,
Nicotinamide riboside,
Zinc
1件: Niacinamide 💬 --13件: 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
308Nicotinamide riboside chloride2件: Nicotinamide,
Nicotinamide riboside
1件: Niacinamide 💬 --1件: 97 💬
309Nicotinamide tablet1件: Nicotinamide1件: Niacinamide 💬 --1件: 46 💬
310Nicotine1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
311Nicotine and cotinine serum levels1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 13 💬
312Nicotine dependence1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 13 💬
313Nicotine GUM1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
314Nicotine patch1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬2件: 6, 84 💬
315Nicotine transdermal patch1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬
16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
316Nicotinell 17,5 MG/24-stunden-pflaster----1件: 6 💬
317Nicotinell 35 MG/24-stunden-pflaster----1件: 6 💬
318Nicotinic acid1件: Niacin1件: Niacin 💬 --1件: 79 💬
319NIDO-361----1件: 1 💬
320Nifedipine1件: Nifedipine1件: Nifedipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 81 💬
321Nifuroxazide1件: Nifuroxazide1件: Nifuroxazide 💬 --1件: 97 💬
322NIL PER OS----1件: 291 💬
323Nilotinib1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬4件: 6, 34, 51, 86 💬
324Nilotinib 150 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 8 💬
325Nilotinib 50 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
326Nilotinib hydrochloride monohydrate1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬
32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
327Nilvadipine1件: Nilvadipine1件: Nilvadipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 90 💬
328Nimenrix1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)2件: Tetanus toxoid adsorbed ,
Tetanus toxoid 💬
--2件: 50, 61 💬
329Nimesulide1件: Nimesulide1件: Nimesulide 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
330Ninlaro----1件: 61 💬
331Nintedanib1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬
8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬
33件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬7件: 51, 84, 85, 89, 227, 228, 331 💬
332Nintedanib 150 MG and 100 MG soft capsules1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬
8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬
33件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227 💬
333Nintendo WII FIT balance board----1件: 13 💬
334Nintendo WII FIT balance exercises1件: Isoxaflutole---1件: 13 💬
335Nintédanib----1件: 227 💬
336Niox mino® airway inflammation monitor----1件: 98 💬
337NIP292 tablet----1件: 85 💬
338NIP292 tablets----1件: 85 💬
339Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
340Nipocalimab 1件: Nipocalimab1件: Nipocalimab 💬 --1件: 11 💬
341Nirs after bosentan administration----1件: 13 💬
342Nirs baseline----1件: 13 💬
343Nitazoxanide1件: Nitazoxanide1件: Nitazoxanide 💬 --1件: 96 💬
344Nitazoxanide 500MG oral tablet1件: Nitazoxanide1件: Nitazoxanide 💬 --1件: 46 💬
345Nitisinone1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 3件: Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 6, 164, 241 💬
346Nitisinone 10 MG tablet high compritol1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 3件: Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
347Nitisinone baked tablet1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 3件: Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
348Nitrate1件: Nitrate1件: Nitric acid 💬 --1件: 299 💬
349Nitrate-depleted beetroot juice1件: Nitrate1件: Nitric acid 💬 --1件: 67 💬
350Nitrate-rich beetroot juice (70ML with approx. 400 MG nitrate) twice A DAY FOR 3 days1件: Nitrate1件: Nitric acid 💬 --1件: 85 💬
351Nitric oxide1件: Nitric Oxide1件: Nitric oxide 💬 --8件: 51, 85, 86, 88, 97, 210, 294, 299 💬
352Nitric oxide 160 PPM1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 299 💬
353Nitric oxide FOR inhalation1件: Nitric Oxide1件: Nitric oxide 💬 --2件: 86, 299 💬
354Nitric oxide generated BY THE geno nitrosyl delivery system1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 86 💬
355Nitric oxide plus oxygen2件: Nitric Oxide,
Oxygen
2件: Oxygen ,
Nitric oxide 💬
--1件: 86 💬
356Nitric oxide supplement1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 251 💬
357Nitrofurantoin1件: Nitrofurantoin1件: Nitrofurantoin 💬 --1件: 13 💬
358Nitrogen1件: Nitrogen1件: Nitrogen 💬 --5件: 5, 6, 17, 211, 299 💬
359Nitroglycerin1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
360Nitroglycerine GEL1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
361Nitrous oxide1件: Nitrous oxide1件: Nitrous oxide 💬 --1件: 34 💬
362Niubangzi pill----1件: 46 💬
363Nivolumab1件: Nivolumab1件: Nivolumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
364Nizoral1件: Ketoconazole1件: Ketoconazole 💬 --1件: 75 💬
365NJ-tube: silicon ED tube----1件: 6 💬
366NK 010 or NK042----1件: 49 💬
367NK cells1件: Natural Killer Cell---3件: 26, 49, 63 💬
368NKX019----2件: 49, 51 💬
369NL-chchd-001----1件: 2 💬
370NL-FLVC-001----1件: 90 💬
371NLE4-D-PHE7-alpha-MSH----1件: 254 💬
372NLX-112----1件: 6 💬
373NLY01----1件: 6 💬
374NM8074----4件: 50, 62, 66, 109 💬
375NMD670----3件: 3, 10, 11 💬
376Nmda1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬
5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
377NN 1841----1件: 288 💬
378NN1841----1件: 288 💬
379NNC 0109-0000-0012----1件: 46 💬
380NNC 0141-0000-0100----1件: 46 💬
381NNC 0142-0000-0002----2件: 46, 96 💬
382NNC 0151-0000-0000----2件: 46, 49 💬
383NNC 142-0002----1件: 46 💬
384NNC0109-0012----1件: 46 💬
385NNC0114-0000-0005----1件: 46 💬
386NNC0114-00061件: NNC0114-0006---3件: 46, 49, 96 💬
387NNC0142-0000-0002----1件: 96 💬
388NNC0142-0002----1件: 46 💬
389NNC0151-0000-0000----1件: 46 💬
390NNC0215-0384----2件: 46, 162 💬
391NNC109-0012----1件: 46 💬
392NNC142-0002----1件: 96 💬
393NNC151-0000----1件: 46 💬
394NNZ-2566----2件: 156, 206 💬
395NNZ-25911件: NNZ-2591---2件: 193, 201 💬
396NO active treatment----1件: 274 💬
397NO ANTI-inflammatory treatment----1件: 271 💬
398NO doxycycline1件: Doxycycline5件: Doxycycline ,
Doxycycline hyclate ,
Doxycycline calcium ,
Doxycycline ,
Doxycycline hydrochloride 💬
--1件: 299 💬
399NO enzyme therapy----1件: 298 💬
400NO intervention, will NOT receive ANY active study intervention----2件: 90, 303 💬
401NO intervention- observational SUB-study----1件: 226 💬
402NO interventional drug product utilized IN this follow-UP study----1件: 20 💬
403NO investigational product----1件: 19 💬
404NO IT treatment----1件: 19 💬
405NO pancreatic enzyme replacement therapy----1件: 299 💬
406NO plasma exchange----2件: 43, 44 💬
407NO treatment----2件: 53, 274 💬
408NO treatment ARM----1件: 13 💬
409NO4bd03----1件: 6 💬
410Nociceptor flexor reflex----1件: 149 💬
411Nocturnal oxygen , nocturnal BI-level positive pressure ventilation----1件: 299 💬
412NOE-101----1件: 158 💬
413Nolpitantium besylate----1件: 97 💬
414Nomacopan1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162 💬
415Nomegestrol1件: Nomegestrol1件: Nomegestrol 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
416Nomegestrol acetate2件: Nomegestrol,
Nomegestrol acetate
2件: Nomegestrol ,
Nomegestrol acetate 💬
1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
417Nomlabofusp1件: Nomlabofusp---1件: 18 💬
418NON applicabile----3件: 49, 51, 256 💬
419NON applicable----2件: 10, 19 💬
420NON AS OF YET----1件: 97 💬
421NON ATG conditioning regimen----1件: 60 💬
422NON commercial----1件: 75 💬
423NON disponibile----2件: 13, 201 💬
424NON intervention-genetic testing----1件: 6 💬
425NON intervention-monitoring device----1件: 6 💬
426NON invasive prenatal diagnosis----3件: 8, 113, 206 💬
427NON invasive ventilation----1件: 299 💬
428NON propietry, therefore N/A----1件: 51 💬
429NON-active stimulation----1件: 46 💬
430NON-ANTI-TNF biologics----2件: 46, 271 💬
431NON-biologic ANTI-rheumatic drugs----1件: 46 💬
432NON-biologic dmards----3件: 46, 86, 107 💬
433NON-biological dmards----1件: 46 💬
434NON-enteric coated pancreatic enzyme preparation----1件: 298 💬
435NON-exposed group----1件: 97 💬
436NON-genotyping----1件: 97 💬
437NON-hormonal period----1件: 299 💬
438NON-mavacamten symptomatic ohcm therapy1件: Mavacamten1件: Mavacamten 💬 1件: MYH6_7 💬 9件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬1件: 58 💬
439NON-motor symptoms----1件: 6 💬
440NON-nucleoside reverse transcriptase inhibitors----1件: 265 💬
441NON-pegylated interferon----1件: 13 💬
442NON-steroidal ANTI-inflammatory drug----1件: 46 💬
443NON-steroidal ANTI-inflammatory drugs----1件: 46 💬
444NON-steroidal mineralocorticoid receptor antagonist and SOC----1件: 66 💬
445NON-TNFI-biologic class----1件: 46 💬
446Nonbiologic dmards OF investigator'S choice----1件: 46 💬
447None AS OF YET----1件: 46 💬
448None assigned----2件: 231, 299 💬
449None AT this time----2件: 96, 140 💬
450None given----1件: 97 💬
451None YET----3件: 51, 85, 222 💬
452Noninvasive actigraphy monitor----1件: 86 💬
453Nonmyeloablative allogeneic hematopoietic stem cell transplantation----6件: 28, 51, 60, 62, 65, 285 💬
454Norantipyrine----1件: 2 💬
455Nordimet 7,5 MG solution injectable EN stylo PRérempli1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬
2件: DHFR,
DHFR 💬
3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
456Norditropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
457Norditropin 24 IU1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
458Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
459Norditropin simplexx1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 97, 193, 195 💬
460Norditropin simplexx 15 MG/1.5 ML1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 3 💬
461Norditropin simplexx 5MG/1.5ML1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 107 💬
462Norditropine simplex----1件: 238 💬
463Norditropin® simplexx® 5MG/1.5ML1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 97 💬
464Norepinephrine1件: Norepinephrine3件: Noradrenaline ,
Norepinephrine bitartrate ,
Norepinephrine hydrochoride 💬
9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 22 💬
465Norepinephrine bitartrate1件: Norepinephrine3件: Noradrenaline ,
Norepinephrine bitartrate ,
Norepinephrine hydrochoride 💬
9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296 💬
466Norethindrone1件: Norethisterone2件: Norethindrone ,
Norethindrone acetate 💬
1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299 💬
467Normal (control) diet----1件: 240 💬
468Normal diet----2件: 96, 97 💬
469Normal dietetic scheme----1件: 97 💬
470Normal human immunoglobulin G----1件: 65 💬
471Normal oral intake OF THE traditional formula----1件: 296 💬
472Normal saline----20件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
473Normal saline 0.9% infusion solution----1件: 22 💬
474Normal saline enema----1件: 97 💬
475Normal saline FOR injection----2件: 13, 84 💬
476Normal saline instillation----1件: 226 💬
477Normal saline IV administration----1件: 65 💬
478Normal saline IV, salt tablets----1件: 299 💬
479Normal saline solution1件: Sodium chloride1件: Sodium chloride 💬 --1件: 299 💬
480Normix*AD 12CPR RIV 200MG----1件: 96 💬
481Norovirus -specific T-cell (NST) therapy----1件: 65 💬
482Norphenazone1件: Edaravone1件: Edaravone 💬 --1件: 2 💬
483Northera1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
484Nortriptyline1件: Nortriptyline2件: Nortriptyline hydrochloride ,
Nortriptyline 💬
2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 226 💬
485Nortriptyline hydrochloride1件: Nortriptyline2件: Nortriptyline hydrochloride ,
Nortriptyline 💬
2件: SLC6A2,
SLC6A4 💬
3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
486Norucholic acid1件: norUrsodeoxycholic acid---1件: 94 💬
487Norucholic acid (NCA) 500 MG1件: norUrsodeoxycholic acid---1件: 93 💬
488Norudca----1件: 94 💬
489Norursodeoxycholic acid1件: norUrsodeoxycholic acid---1件: 94 💬
490Norursodeoxycholic acid, NCA1件: norUrsodeoxycholic acid---1件: 94 💬
491Norvir1件: Ritonavir1件: Ritonavir 💬 --1件: 265 💬
492Norvir 100 MG FILM-coated tablets----1件: 299 💬
493NOT applicable----1件: 13 💬
494NOT YET assigned----2件: 36, 97 💬
495Novantrone*INF 2MG/ML 5ML1件: Mitoxantrone2件: Mitoxantrone hydrochloride ,
Mitoxantrone 💬
--1件: 13 💬
496Novartis pharmaceuticals corporation----1件: 13 💬
497Novatrex----1件: 13 💬
498Novo rapid----1件: 299 💬
499Novolin-R insulin----1件: 127 💬
500Novonorm 0.5 MG----1件: 299 💬
501Novonorm 1 MG----1件: 299 💬
502Novonorm 2 MG----1件: 299 💬
503Novorapid / humalog short acting insulin----1件: 299 💬
504Novorapid aspartate----1件: 299 💬
505NOW foods L-ornithine capsules----1件: 96 💬
506NOX-E36----1件: 49 💬
507Noxafil1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
508Noxafil - 40 MG/ML sospensione orale USO orale flacone (vetro) 105 ML 1 flacone----1件: 299 💬
509Noxafil - oral suspension 40 MG/ML1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
510Noxafil 100 MG1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
511Noxafil 100 MG tablets gastro-resistant1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
512Noxafil 40 MG/ML oral solution1件: Posaconazole1件: Posaconazole 💬 --1件: 65 💬
513Noxafil gastro resistant tablets----1件: 60 💬
514NP001----2件: 2, 17 💬
515NP031112 600MG----1件: 5 💬
516NP031112 800MG----1件: 5 💬
517NPB-01----3件: 13, 14, 162 💬
518NPC transplantation----1件: 6 💬
519NPC-02----1件: 171 💬
520NPC-09----1件: 30 💬
521NPC-12G GEL----2件: 34, 158 💬
522NPC-12Y GEL----1件: 158 💬
523NPC-14----1件: 113 💬
524NPI-001----2件: 90, 303 💬
525NPL-2009----1件: 206 💬
526Nplate1件: Romiplostim1件: Romiplostim 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
527Nplate 500 microgramos polvo para solucióN inyectable1件: Romiplostim1件: Romiplostim 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
528Npsp 558----1件: 235 💬
529NPSP558----1件: 235 💬
530NR082 injection----1件: 302 💬
531NS----1件: 96 💬
532NS 2330----1件: 6 💬
533NS-050/NCNP-03----1件: 113 💬
534NS-065/NCNP-01----1件: 113 💬
535NS-089/NCNP-02----1件: 113 💬
536NS-229----2件: 44, 45 💬
537NS-304----1件: 86 💬
538NS2330----1件: 6 💬
539Nsaid----2件: 270, 271 💬
540Nsaids----4件: 46, 70, 107, 271 💬
541Nsaids and sulfasalazine----1件: 271 💬
542Nsnsaids----2件: 107, 271 💬
543NSP001----1件: 96 💬
544NT 101----4件: 5, 6, 7, 17 💬
545NT-5011件: Ciliary neurotrophic factor---2件: 90, 303 💬
546NT-I71件: Efineptakin alfa1件: Efineptakin alfa 💬 --1件: 25 💬
547NT-KO-003----1件: 13 💬
548Ntbc----1件: 241 💬
549Ntcell implantation----1件: 6 💬
550NTI164----1件: 156 💬
551NTLA-20011件: NTLA-2001---1件: 28 💬
552NTLA-20021件: NTLA-2002---1件: 65 💬
553NTQ5082----1件: 62 💬
554NTQ5082 capsules 100 MG----1件: 66 💬
555NTQ5082 capsules 200 MG----1件: 66 💬
556NTQ5082 capsules 300 MG----1件: 66 💬
557NU100----1件: 13 💬
558Nucala1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
559Nucala 100 MG powder FOR solution FOR injection1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
560Nucel----1件: 70 💬
561Nucleomaxx----1件: 265 💬
562Nucleoside analogue sparing haart regimen----1件: 265 💬
563Nuedexta----1件: 2 💬
564Nulojix----1件: 46 💬
565Numerical rating scale----1件: 46 💬
566Nuplazid1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2,
HTR2 💬
6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
567Nuplazid 34 MG oral capsule1件: Pimavanserin1件: Pimavanserin tartrate 💬 2件: HTR2,
HTR2 💬
6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
568Nursinersen----1件: 3 💬
569Nusinersen1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬
--1件: 3 💬
570Nusinersen injectable product1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬
--1件: 3 💬
571Nusinersen sodium1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬
--1件: 3 💬
572Nusinersen treatments1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬
--1件: 3 💬
573Nutraceutical combination----1件: 96 💬
574Nutridrink-impact----1件: 299 💬
575Nutrition counseling----1件: 298 💬
576Nutrition specialist----1件: 97 💬
577Nutrition supplement----1件: 97 💬
578Nutrition treat----1件: 96 💬
579Nutritional assessment----1件: 6 💬
580Nutritional dietary intervention----2件: 96, 97 💬
581Nutritional formulation containing exogenous ketones----1件: 201 💬
582Nutritional ketone supplement----2件: 317, 344 💬
583Nutritional supplement----1件: 90 💬
584Nutropin AQ1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 78, 134, 193, 299 💬
585Nutropinaq 10MG/2ML (30 I.E.) injektionsllösung1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 65 💬
586Nutropinaq 10MG/2ML solution FOR injection1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 96 💬
587NV1205----1件: 20 💬
588NVF233----1件: 13 💬
589NW-1015----1件: 6 💬
590NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
591NX-13 250 MG----1件: 97 💬
592NX-13 250MG----1件: 97 💬
593NX-13 250MG IR----1件: 97 💬
594NX-13 500MG IR----1件: 97 💬
595NX-13 500MG MR----1件: 97 💬
596NX-13 750MG----1件: 97 💬
597NX1011----1件: 86 💬
598NX210C----1件: 2 💬
599NXC-201 CAR-T----1件: 28 💬
600NYX-458----1件: 6 💬
601Nébivolol----1件: 113 💬